These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19609726)

  • 1. On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children.
    Peshkin BN; Demarco TA; Tercyak KP
    Fam Cancer; 2010 Mar; 9(1):89-97. PubMed ID: 19609726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
    Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
    Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care providers' willingness to recommend BRCA1/2 testing to adolescents.
    O'Neill SC; Peshkin BN; Luta G; Abraham A; Walker LR; Tercyak KP
    Fam Cancer; 2010 Mar; 9(1):43-50. PubMed ID: 19390990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.
    Sharff ME; DeMarco TA; Mays D; Peshkin BN; Valdimarsdottir HB; Garber JE; Schneider KA; Patenaude AF; Tercyak KP
    Genet Test Mol Biomarkers; 2012 May; 16(5):376-82. PubMed ID: 22085394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).
    Peshkin BN; DeMarco TA; Garber JE; Valdimarsdottir HB; Patenaude AF; Schneider KA; Schwartz MD; Tercyak KP
    J Pediatr Psychol; 2009 Jul; 34(6):627-38. PubMed ID: 18385162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Tool to Guide Parents Carrying a BRCA1/2 Mutation Share Genetic Results with Underage Children.
    Santerre-Theil A; Bouchard K; St-Pierre D; Drolet AM; Chiquette J; Dorval M;
    J Cancer Educ; 2018 Jun; 33(3):569-575. PubMed ID: 27804029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.
    Demarco TA; Nusbaum RH; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Tercyak KP
    Patient Educ Couns; 2010 Jan; 78(1):29-33. PubMed ID: 19545972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.
    Mays D; DeMarco TA; Luta G; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Tercyak KP
    Health Psychol; 2014 Aug; 33(8):765-73. PubMed ID: 23795707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing.
    Doughty Rice C; Ruschman JG; Martin LJ; Manders JB; Miller E
    Fam Cancer; 2010 Jun; 9(2):203-12. PubMed ID: 20473602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communication with patients during the prenatal testing procedure: an explorative qualitative study.
    van Zwieten M; Willems D; Knegt L; Leschot N
    Patient Educ Couns; 2006 Oct; 63(1-2):161-8. PubMed ID: 16406463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.
    Tercyak KP; Peshkin BN; Streisand R; Lerman C
    Psychooncology; 2001; 10(4):336-46. PubMed ID: 11462232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
    Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N
    Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families.
    Peshkin BN; Ladd MK; Isaacs C; Segal H; Jacobs A; Taylor KL; Graves KD; O'Neill SC; Schwartz MD
    J Cancer Educ; 2021 Feb; 36(1):72-84. PubMed ID: 31402434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children.
    Tercyak KP; Mays D; DeMarco TA; Peshkin BN; Valdimarsdottir HB; Schneider KA; Garber JE; Patenaude AF
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1260-6. PubMed ID: 23825307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives.
    Hamilton JG; Peshkin BN; Mays D; DeMarco TA; Patenaude AF; Tercyak KP
    Psychooncology; 2018 Jul; 27(7):1825-1832. PubMed ID: 29645321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
    Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
    Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.